porphobilinogen has been researched along with thiazolidines in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Panda, D; Rai, A; Surolia, A | 1 |
1 other study(ies) available for porphobilinogen and thiazolidines
Article | Year |
---|---|
An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.
Topics: Animals; Calcium-Binding Proteins; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Drug Screening Assays, Antitumor; Humans; Kinetochores; Mad2 Proteins; Mice; Microtubules; Mitotic Index; Neoplasms; Polymerization; Porphobilinogen; Protein Serine-Threonine Kinases; Repressor Proteins; Rhodanine; Thiazolidines; Thiones; Tubulin; Tubulin Modulators; Tumor Suppressor Protein p53; Vinblastine | 2012 |